Humira Market to Decline to USD 6.90 Billion by 2032 Amid Intensifying Biosimilar Competition and Patent Expirations

0
1K

According to a report by Intel Market Research, the global Humira Market was valued at USD 13.12 billion in 2024 and is projected to decline from USD 12.08 billion in 2025 to USD 6.90 billion by 2032, registering a negative CAGR of -9.0% during the forecast period. The market is undergoing a significant transformation following the expiration of key patents and the rapid entry of biosimilar competitors, resulting in increased pricing pressure and substantial market share erosion for the originator product.

Humira (adalimumab), a tumor necrosis factor (TNF) inhibitor developed by AbbVie, has long been one of the world's best-selling biologic therapies. The drug is widely used for the treatment of chronic inflammatory and autoimmune conditions, including rheumatoid arthritis, psoriatic arthritis, ankylosing spondylitis, Crohn’s disease, ulcerative colitis, and plaque psoriasis. Its broad range of approved indications and extensive clinical history have established Humira as a cornerstone therapy across multiple medical specialties.

Download Sample Report: https://www.intelmarketresearch.com/humira-market-market-16317

The market's contraction is primarily driven by the loss of patent exclusivity in major markets, particularly the United States, where multiple biosimilar versions of adalimumab entered the market following patent expiration in 2023. Biosimilar manufacturers are offering lower-cost alternatives, encouraging healthcare providers, insurers, and pharmacy benefit managers to adopt more cost-effective treatment options. As a result, pricing competition has intensified, accelerating the decline in revenue generated by the branded Humira product.

Despite these challenges, demand for adalimumab-based therapies remains strong due to the growing prevalence of chronic inflammatory diseases worldwide. Rising diagnosis rates, expanding healthcare access, and increasing awareness of autoimmune disorders continue to support treatment adoption. Additionally, the availability of lower-cost biosimilars is improving patient access to biologic therapies, particularly in emerging markets where affordability has historically been a barrier.

Manufacturers are focusing on product differentiation strategies, including high-concentration citrate-free formulations, enhanced patient support programs, and improved self-administration devices to retain patient loyalty and maintain market presence. Furthermore, opportunities remain in emerging economies across Asia-Pacific, Latin America, and the Middle East, where expanding healthcare infrastructure and growing demand for advanced biologic treatments are expected to support future market growth.

North America remains the largest regional market due to its high biologic therapy adoption rates, established reimbursement systems, and large patient population. However, Europe continues to lead in biosimilar adoption, creating a highly competitive environment that serves as a model for future market developments worldwide.

Key Players Operating in the Humira Market:

  • AbbVie Inc.
  • Amgen Inc.
  • Boehringer Ingelheim
  • Sandoz International GmbH (Novartis)
  • Coherus BioSciences, Inc.
  • Fresenius Kabi
  • Viatris Inc.
  • Organon & Co.
  • Pfizer Inc.
  • Samsung Bioepis
  • Cadila Healthcare Ltd. (Zydus Cadila)
  • Torrent Pharmaceuticals Ltd.
  • Eisai Co., Ltd.
  • Celltrion Inc.

Download Sample Report: https://www.intelmarketresearch.com/humira-market-market-16317

Get Full Report: https://www.intelmarketresearch.com/humira-market-market-16317

As the global biologics landscape continues to evolve, market participants are expected to focus on competitive pricing strategies, biosimilar expansion, product innovation, and patient-centric solutions to navigate the changing dynamics of the Humira market and capitalize on emerging opportunities worldwide.

🌐 Website: https://www.intelmarketresearch.com

πŸ“ž Asia-Pacific: +91 9169164321 πŸ”—

 LinkedIn: Follow Us

 

Cerca
Categorie
Leggi tutto
Altre informazioni
Omics Lab Services Market Projected to Reach $245.69 Billion by 2032 with 13.4% CAGR
Polaris Market Research has introduced the latest market research report titled Omics Lab...
By Prajwal Agale 2025-11-26 09:56:19 0 2K
Altre informazioni
Micro Server Market Size, Cloud Demand & Future Outlook 2026–2033
"Micro Server Market Summary: According to the latest report published by Data Bridge Market...
By Sonali Sonkusare 2026-04-29 11:03:49 0 1K
Film
Viral only fans milica Recent Media Updates Latest News
πŸ”₯ VIRAL VIDEO TRENDING RIGHT NOW πŸ‘‰ WATCH HERE NOW 😱 PEOPLE REGRET NOT WATCHING THIS EARLIER πŸŽ₯...
By Nuhvaj Nuhvaj 2026-07-17 01:34:54 0 904
Shopping
Trapstar Tracksuit & Pink Palm Puff Hoodie in winter season 2026 fashion picks
Winter 2026 arrives with a decisive shift in fashion consciousness. Practicality no longer exists...
By Trapstar Hoodie 2026-02-04 06:40:51 0 2K
Film
News XNXX((((Porn.Videos)))) desi hard sex video xnxx video 206 desi hard sex video Latest News
🚨πŸ”₯ WATCH FULL VIDEO NOW πŸ‘€ πŸ‘‰ CLICK HERE TO WATCH 🎬 😱 YOU WON'T BELIEVE THE ENDING πŸ”₯ WATCH THE...
By Nuhvaj Nuhvaj 2026-07-23 23:01:37 0 732